472-P: Pro-B-Type Natriuretic Peptide Strongly Predicts Future Cardiovascular Events in Cardiovascular Disease Patients with NAFLD as Well as in Those without NAFLD

Author:

MAECHLER MAXIMILIAN1,SPRENGER LUKAS1,MADER ARTHUR1,LARCHER BARBARA1,VONBANK ALEXANDER1,PLATTNER THOMAS1,LEIHERER ANDREAS1,MUENDLEIN AXEL1,DREXEL HEINZ1,SAELY CHRISTOPH H.1

Affiliation:

1. Feldkirch, Austria, Triesen, Liechtenstein

Abstract

Elevated pro-B type natriuretic peptide (pro-BNP) has been found to be a strong marker of cardiovascular risk in several high-risk populations. However, the power of pro-B type natriuretic peptide (pro-BNP) to predict future cardiovascular events in patients with the combination of established cardiovascular disease and nonalcoholic fatty liver disease (NAFLD) is unclear and is addressed in the present study. We enrolled 794 patients with established cardiovascular disease, 553 with angiographically proven stable CAD and 241 with sonographically proven peripheral artery disease. Prospectively, cardiovascular events were recorded over a mean follow-up period of 8.7±3.3 years. At baseline, pro-BNP was not significantly different in patients with NAFLD (n=394) than in those who did not have NAFLD (796±2208 vs. 798±2520 pg/ml; p=0.234). During follow-up, 376 patients suffered cardiovascular events; the event rate was significantly higher in patients with NAFLD than in subjects without NAFLD (56.6 vs. 43.4%; p<0.001). Pro-BNP predicted cardiovascular events in the total study population, with a standardized adjusted hazard ratio (HR) of1.36 [1.26-1.46]; p<0.001. Further, pro-BNP predicted cardiovascular events in patients with NAFLD (HR 1.45 [1.28-1.65]; p<0.001) as well as in those who did not have NAFLD (HR 1.34 [1.19-1.50]; p<0.001). Interaction terms pro-BNP x NAFLD were non-significant for cardiovascular events (p=0.198), indicating that the power of pro-BNP to predict cardiovascular events did not differ significantly between cardiovascular disease patients with NAFLD and those who did not have NAFLD. We conclude that pro-BNP strongly predicts cardiovascular events in cardiovascular disease patients with NAFLD as well as in those without NAFLD. Disclosure M. Maechler: None. L. Sprenger: None. A. Mader: None. B. Larcher: None. A. Vonbank: None. T. Plattner: None. A. Leiherer: None. A. Muendlein: None. H. Drexel: None. C.H. Saely: None.

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3